Showing 15,661 - 15,680 results of 101,630 for search '(( 5 wt decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.84s Refine Results
  1. 15661
  2. 15662
  3. 15663
  4. 15664
  5. 15665

    Supplementary Material for: Hyperfunctioning Papillary Thyroid Carcinoma with a <b><i>BRAF</i></b> Mutation: The First Case Report and a Literature Review by Shinkai S. (10260734)

    Published 2021
    “…Subsequent mutational analysis of <i>BRAF</i> (exon 15), <i>TSHR</i> (exons 1–10), <i>GNAS</i> (exons 7–10), <i>EZH1</i> (exon 16), <i>KRAS</i>, <i>NRAS</i>, <i>HRAS</i> (codons 12, 13, and 61), and <i>TERT</i> promoter (C250T and C228T) identified a heterozygous point mutation in <i>BRAF</i> V600E in a tumor tissue sample. …”
  6. 15666

    Table1_Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning.docx by Yaqi Zhong (19526857)

    Published 2024
    “…In vivo experiments showed that EIF5A knockdown led to increased infiltration of CD8+ T cells and M1 macrophages, and decreased M2 macrophages and Tregs following radiation therapy, thereby enhancing the radiotherapy response.…”
  7. 15667

    Supplementary Figures 1-5 from A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance by Lina Y. Dimberg (15077439)

    Published 2023
    “…Supplemental Figure 4: BJAB-LexR cells have increased SLC26A2 and decreased DR4 and DR5. Supplemental Figure 5: SLC26A2 expression correlates with Metastasis prognosis.…”
  8. 15668
  9. 15669

    Pre-treatment with GnRHa or <i>ulipristal acetate</i> prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis by Inge de Milliano (4515127)

    Published 2017
    “…Pre-treatment with GnRHa before laparoscopic myomectomies also shows a reduction in intra-operative blood loss by 23.03ml (95% CI -40.79 to -5.27) and in the frequency of blood transfusions (OR 0.17, 95% CI 0.05 to 0.55) compared to no pre-treatment.…”
  10. 15670

    Data of GO analysis. by Haoting Wang (16952764)

    Published 2024
    “…Here, we generated KO mice of other <i>Garins</i>, namely <i>Garin2</i>, <i>Garin3</i>, <i>Garin4</i>, <i>Garin5a</i>, and <i>Garin5b</i> (<i>Garin2-5b</i>). …”
  11. 15671

    Sequences used for phylogenetic analyses. by Haoting Wang (16952764)

    Published 2024
    “…Here, we generated KO mice of other <i>Garins</i>, namely <i>Garin2</i>, <i>Garin3</i>, <i>Garin4</i>, <i>Garin5a</i>, and <i>Garin5b</i> (<i>Garin2-5b</i>). …”
  12. 15672
  13. 15673
  14. 15674
  15. 15675
  16. 15676

    Treatment adoption and diffusion pattern. by Frédéric Galacteros (11105678)

    Published 2023
    “…In clinical studies, voxelotor has been shown to increase hemoglobin (Hb) and decrease hemolytic markers in patients with SCD. The objective of this study was to estimate the impact of voxelotor on the burden of SCD in France using a modeling approach, accounting for its anticipated adoption and diffusion over the next 5 years. …”
  17. 15677
  18. 15678

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    “…The present study found that the mean number of patients treated for TB declined by 35 patients (β: -34.62; 95%CI: -50.29, -18.95) compared to the pre-COVID-19 era while the number of new patients enrolled for ART decreased by 71 patients (β: -70.62; 95%CI: -107.19, -34.05). …”
  19. 15679
  20. 15680